ADIPOQ and adenoma: In each of three case-control studies of Japanese men and women there was a statistically significant association between circulating adiponectin and adenoma risk, with decreases in odds of adenoma ranging between 44% and 76% with every 1 μg/mL increase in total adiponectin [20, 21, 23].